She had stage IV ovarian cancer, and her chances of survival were grim. This September, more than 10 years later, Polo ...

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede ...

Researchers at Weill Cornell Medicine have shown that ovarian cancers disable immune cells and prevent them from attacking by ...

Cubillos-Ruiz said. When Dr. Hwang and his colleagues tested CAR T cells, which are currently being evaluated in clinical trials, in mouse models of metastatic ovarian cancer, they found the same ...

本文已于2024年10月9日被撤回： 本文已由主编要求撤回。对图2D、图4C、图5B和图6B的可靠性提出了质疑。此外，在提供的原始数据集中，似乎存在部分或完全相同的额外图像，而这些图像却代表着不同的样本。相关图像的详细信息如下： ...

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack - blocking the ...

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Dr. Elizabeth Comen, a medical oncologist specializing in breast cancer at NYU Langone Health and best-selling author of “All in Her Head,” shared with us everything you need to know about breast ...

The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing ...

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for ...

There are no approved therapies to tackle c-Met protein overexpression, AbbVie said in a press release. C-Met is a receptor ...